Zielinski, R. R., Azad, A. A., Chi, K. N., & Tyldesley, S. (2014). Population-based impact on overall survival after the introduction of docetaxel as standard therapy for metastatic castration resistant prostate cancer. Canadian Urological Association Journal, 8(7-8), e520–3. https://doi.org/10.5489/cuaj.2076